Stock market Updates | IOL Chemicals & Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY14310.80  -524.05 (-3.53%)
SENSEX47883.38  -1707.94 (-3.44%)
  • top gainers
  • top losers
  • top volume
  • top value
investments Associate Login Online Trading Login
  • indian indices
  • global indices

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage. investment advisory, financial integrity and prompt services in the whole of South Gujarat.

L
equity
Home Markets & NewsCompany ProfileSmart Quotes

IOL CHEMICALS & PHARMACEUTICALS LTD.

NSE : IOLCPBSE : 524164ISIN CODE : INE485C01011Industry : Pharmaceuticals & DrugsHouse : Trident
BSE582.40-51.75 (-8.16 %)
PREV CLOSE (Rs.) 634.15
OPEN PRICE (Rs.) 624.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 215089
TODAY'S LOW / HIGH (Rs.)577.55 625.00
52 WK LOW / HIGH (Rs.)235 898.4
NSE583.95-50.3 (-7.93 %)
PREV CLOSE( Rs. ) 634.25
OPEN PRICE (Rs.) 625.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1207397
TODAY'S LOW / HIGH(Rs.) 576.70 626.00
52 WK LOW / HIGH (Rs.)230.2 898.9

Smart Quotes

BSE NSE
1D 1M 3M 1Y 3Y 5Y
Stock Summary
Trade Value (Rs. in Lacs)
1278.27
Dividend Yield(%)
0.52
TTM EPS (Rs.)
78.28
P/E Ratio
7.44
Book Value (Rs.)
186.49
Face Value (Rs.)
10
MCap (Rs. in Mn)
34190.08
Price/Earning (TTM)
6.87
Price/Sales (TTM)
1.76
Price/Book (MRQ)
3.12
PAT Margin (%)
19.07
ROCE (%)
68.09
company info
Incorporation Year : 1986

Management Info :

Rajender Mohan Malla - Chairman Varinder Gupta - Managing Director

Registered Office :

Address : Village & Post Office,Handiaya,Fatehgarh Chhanna Road,
Barnala,
Punjab-148107

Phone : +91-1679- 244701 / 244702 / 244703 / 04 / 05 / 06 / 07

Website : www.iolcp.com

Registrars Details :

Alankit Assignments Ltd.
Alankit House , 4 E/2,Jhandewala Extension,,New Delhi
Listing : BSE, NSE, MCX
News
31Mar Announcement under Regulation 30 (LOD
Pursuant to Regulation 30 of Securities and Exchange Board of India (Lis..
17Mar Intimation Of Appointment Of Chief Ex
The Board of Directors of the Company at its Meeting held on 16th March..
16Mar Appointment of CEO
Inter alia, has appointed Dr. Sanjay Chaturvedi as Chief Executive Offic..
more
Financials
QTR Dec 20 ANNUAL 20
Net Profit1148.13612.9
Gross Profit 1536.3 5332.4
Operating Profit 1650.6 5899
Net Sales 5130.1 18944.7
more
Rs. in Millions
Rolling Forward P/E (EOD)
Event Calendar
peer group
Dr. Reddys Lab (BSE)
Rwadiwala-peer-arrow  4989.20 (4.83%)
M.Cap (Rs. in Cr)82971.01
Astrazeneca Pharma I (BSE)
Rwadiwala-peer-arrow  3398.00 (2.51%)
M.Cap (Rs. in Cr)8495.00
Solara Active Pharma (BSE)
Rwadiwala-peer-arrow  1440.90 (5.11%)
M.Cap (Rs. in Cr)5177.12
Ipca Laboratories (BSE)
Rwadiwala-peer-arrow  2153.75 (3.29%)
M.Cap (Rs. in Cr)27320.77
Shareholding Pattern
NON-INSTITUTION
48.48%
PROMOTERS
43.69%
MUTUAL FUNDS/UTI
0.03%
FI/BANKS/INSURANCE
0%
GOVERNMENT
0%
FII
0%
more
Mf Holdings
ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.    
CORPORATE OFFICE
address
  • 9/2003-4,
  • Vishnu Priya Limda Chowk
  • Main Road
  • Surat – 395 003.
fax us @ +91-261-6673537
email us @ info@rwadiwala.com

Feed Back  | Terms & Conditions  | SEBI  | FMC  | NSE  | BSE  | MCX  | NCDEX  | IRDA  |  AMFI  | Disclaimer  | Privacy Policy  | Careers | User Agreements  | Ethics Policy  | Investor Protection  |  Dos and Don'ts   |  Rights and Obligations   |  Uniform Risk Disclosure   |   Important Policies   |  To File A Complaint on SCORES   | Sitemap 

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Copyright © 2016 | All Rights Reserved. R.Wadiwala group.

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.